Data for: Characteristics of Trials and Regulatory Pathways Leading to US Approval of Innovative Vs. Non-Innovative Oncology Drugs
收藏官方服务：
资源简介：
Research Data
应用场景：
创建时间：
2021-04-26
相关数据集
Oncology Based In-vivo CRO Market
Global Oncology Based In-vivo CRO Market Report 2024 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market
IMR REPORTS50
Discovery of Histone Deacetylase 8‑Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological Malignancies
Histone deacetylase 8 (HDAC8) has emerged as promising therapeutic target for several malignancies. In this study, we developed two series of cereblon (CRBN)-recruiting proteolysis-targeting chimeras
NIAID Data Ecosystem30
Information from Health Canada, Food and Drug Administration and European Medicines Agency used in the analysis of the drugs considered in this study.
Information from Health Canada, Food and Drug Administration and European Medicines Agency used in the analysis of the drugs considered in this study.
Figshare2023-06-15 更新10
Discovery of Novel Bifunctional Agents as Potent TRK Inhibitors and Degraders against xDFG Mutation Resistance
Despite the clinical success of tropomyosin receptor kinases (TRKs) inhibitors in NTRK fusion–positive cancers, prolonged administration has resulted in acquired resistance, particularly xDFG mutation
NIAID Data Ecosystem50
Novel Triazoloquinoxaline-Based Tubulin Polymerization Inhibitor Induces Necroptosis and Significantly Inhibits Metastatic Melanoma Tumor Growth
Metastatic melanoma is the deadliest form of skin cancer, being responsible for 80% of skin cancer deaths. Small molecule colchicine-binding site inhibitors have previously demonstrated preclinical th
Figshare10
